WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

ORPHAN DISEASE AND MARKETING STRATEGIES FOR DRUG PRODUCTION

Tanuj Upadhyay*, Richa Saxena and Sachin Sisodiya

Abstract

Orphan drug medications are medicaments to battle, analyzed and counteraction unprecedented uncommon infections (Pasireotide, Tecovirimat, Ivosidenib), etc. Often these drugs are not accessible in India because of high costs ODA (ORPHAN DRUG ACT) is first started by the USA. The enactment and the approaches are some degree comparative yet not equivalent. It is imperative to comprehend the primary contrast among all accessible authoritative framework to improve worldwide coordinated effort in the field of medication and uncommon infection All global pharmaceutical industries is anticipating vagrant medications give financing clinical preliminaries where India is lagging which can be the reason for the crisis. The main Motive behind ODA was to boost R and D trails for such medications to treat a huge number of populace experiencing "Rare diseases." Though the level of patients experiencing "uncommon ailments" in India is allegedly higher than the world normal, shockingly even today such cases get little assistance from our administration. Indian government ought to likewise energize its household pharmaceutical industry to get occupied with a look into vagrant medications by putting an "ODA" set up and broadening money-related help, and administrative concessions like littler and shorter clinical preliminaries, immediately. Therefore, India could well‑demonstrate that the idea of vagrant medications for vagrant ailments is truly not vagrant in India. Vagrant medication possession by socially persuaded not‐for‐profit associations may encourage access to progressively reasonable vagrant medications, to serve patients and human services frameworks the same.

Keywords: Orphan drug, Orphan drug act (ODA), Global pharmaceuticals, Uncommon ailments, Medication, etc.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More